Hoffman La Roche is severing its ties to Big Pharma.
First it was the UK's ABPI.
Now the venerable drug maker this week plans to drop its membership in the Pharmaceutical Research and Manufacturers Association.
PhRMA, as it is known informally, is the leading trade group for the U.S. pharmaceutical industry.
After taking over a biotech giant and relocating to its windswept corporate campus in South San Francisco, Roche is shedding its century-old identity as a traditional U.S. pharmaceutical company.
As part of its evolution, Roche is aligning itself with a new lobbying force, the Biotech Industry Organization (BIO) and plans to pull out of another pharma-related affiliation, its sponsorship of a special pharmaceutical management program at Rutgers Business School.
Now the venerable drug maker this week plans to drop its membership in the Pharmaceutical Research and Manufacturers Association.
PhRMA, as it is known informally, is the leading trade group for the U.S. pharmaceutical industry.
After taking over a biotech giant and relocating to its windswept corporate campus in South San Francisco, Roche is shedding its century-old identity as a traditional U.S. pharmaceutical company.
As part of its evolution, Roche is aligning itself with a new lobbying force, the Biotech Industry Organization (BIO) and plans to pull out of another pharma-related affiliation, its sponsorship of a special pharmaceutical management program at Rutgers Business School.
No comments:
Post a Comment